Burne R - Search Results

1

Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.

Shadman M, Manzoor BS, Sail K, Tuncer HH, Allan JN, Ujjani C, Emechebe N, Kamalakar R, Coombs CC, Leslie L, Barr PM, Brown JR, Eyre TA, Rampotas A, Schuh A, Lamanna N, Skarbnik A, Roeker LE, Bannerji R, Eichhorst B, Fleury I, Davids MS, Alhasani H, Jiang D, Hill BT, Schuster SJ, Brander DM, Pivneva I, Burne R, Guerin A, Mato AR. Shadman M, et al. Among authors: burne r. Clin Lymphoma Myeloma Leuk. 2023 Jul;23(7):515-526. doi: 10.1016/j.clml.2023.03.010. Epub 2023 Mar 24. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37076367 Free article.

2

Treatment and Monitoring Patterns Among Premenopausal Women with HR+/HER2- Advanced Breast Cancer.

Dalal AA, Gauthier G, Gagnon-Sanschagrin P, Burne R, Guérin A, Niravath P, Small T. Dalal AA, et al. Among authors: burne r. Adv Ther. 2018 Sep;35(9):1356-1367. doi: 10.1007/s12325-018-0764-3. Epub 2018 Aug 13. Adv Ther. 2018. PMID: 30105655

3

Dosing Patterns and Economic Burden of Palbociclib Drug Wastage in HR+/HER2- Metastatic Breast Cancer.

Dalal AA, Gagnon-Sanschagrin P, Burne R, Guérin A, Gauthier G, Small T, Niravath P. Dalal AA, et al. Among authors: burne r. Adv Ther. 2018 Jun;35(6):768-778. doi: 10.1007/s12325-018-0701-5. Epub 2018 Jun 4. Adv Ther. 2018. PMID: 29869106

4

Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitors.

Burne R, Balu S, Guérin A, Bungay R, Sin R, Paul ML. Burne R, et al. J Med Econ. 2021 Jan-Dec;24(1):806-815. doi: 10.1080/13696998.2021.1939705. J Med Econ. 2021. PMID: 34098827 Free article.

5

In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States.

Greene SJ, Triana TS, Ionescu-Ittu R, Burne RM, Guérin A, Borentain M, Kessler PD, Tugcu A, DeSouza MM, Felker GM, Chen L. Greene SJ, et al. Among authors: burne rm. JACC Heart Fail. 2020 Nov;8(11):943-953. doi: 10.1016/j.jchf.2020.05.013. Epub 2020 Aug 12. JACC Heart Fail. 2020. PMID: 32800512 Free article.

6

Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States.

Volk ML, Burne R, Guérin A, Shi S, Joseph GJ, Heimanson Z, Ahmad M. Volk ML, et al. Among authors: burne r. J Med Econ. 2021 Jan-Dec;24(1):202-211. doi: 10.1080/13696998.2021.1877148. J Med Econ. 2021. PMID: 33464935 Free article.

7

Economic Burden of HR+/HER2- Metastatic Breast Cancer Among Adult Premenopausal Women.

Gauthier G, Gagnon-Sanschagrin P, Guérin A, Burne R, Small T, Niravath P, Dalal AA. Gauthier G, et al. Among authors: burne r. Adv Ther. 2018 Apr;35(4):503-514. doi: 10.1007/s12325-018-0689-x. Epub 2018 Mar 20. Adv Ther. 2018. PMID: 29556908

8

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review.

Mohr P, Kiecker F, Soriano V, Dereure O, Mujika K, Saiag P, Utikal J, Koneru R, Robert C, Cuadros F, Chacón M, Villarroel RU, Najjar YG, Kottschade L, Couselo EM, Koruth R, Guérin A, Burne R, Ionescu-Ittu R, Perrinjaquet M, Zager JS. Mohr P, et al. Among authors: burne r. Melanoma Manag. 2019 Oct 4;6(4):MMT33. doi: 10.2217/mmt-2019-0015. Melanoma Manag. 2019. PMID: 31871622 Free PMC article.

9

Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive.

Ghate S, Ionescu-Ittu R, Burne R, Ndife B, Laliberté F, Nakasato A, Duh MS. Ghate S, et al. Among authors: burne r. Melanoma Res. 2019 Jun;29(3):301-310. doi: 10.1097/CMR.0000000000000504. Melanoma Res. 2019. PMID: 30247203 Free PMC article.

10

Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma.

Tarhini A, Ghate SR, Ionescu-Ittu R, Manceur AM, Ndife B, Jacques P, Laliberté F, Nakasato A, Burne R, Duh MS. Tarhini A, et al. Among authors: burne r. Melanoma Res. 2018 Dec;28(6):618-628. doi: 10.1097/CMR.0000000000000507. Melanoma Res. 2018. PMID: 30216199 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters